Cerebrospinal fluid analyses of patients with Alzheimer’s disease who are Apo Ɛ4 carriers have also been shown to have low levels of SAM; however, this is not routine practice for work up and diagnosis [7]. This evidence concerns the gene AOPEP and early-onset autosomal dominant Alzheimer disease.